» Articles » PMID: 28832746

Evaluation of Quality of Life in Patients with and Without Heart Failure in Primary Care

Abstract

Background: Heart failure (HF) is a major public health issue with implications on health-related quality of life (HRQL).

Objective: To compare HRQL, estimated by the Short-Form Health Survey (SF-36), in patients with and without HF in the community.

Methods: Cross-sectional study including 633 consecutive individuals aged 45 years or older, registered in primary care. The subjects were selected from a random sample representative of the population studied. They were divided into two groups: group I, HF patients (n = 59); and group II, patients without HF (n = 574). The HF group was divided into HF with preserved ejection fraction (HFpEF - n = 35) and HF with reduced ejection fraction (HFrEF - n = 24).

Results: Patients without HF had a mean SF-36 score significantly greater than those with HF (499.8 ± 139.1 vs 445.4 ± 123.8; p = 0.008). Functional capacity - ability and difficulty to perform common activities of everyday life - was significantly worse (p < 0.0001) in patients with HF independently of sex and age. There was no difference between HFpEF and HFrEF.

Conclusion: Patients with HF had low quality of life regardless of the syndrome presentation (HFpEF or HFrEF phenotype). Quality of life evaluation in primary care could help identify patients who would benefit from a proactive care program with more emphasis on multidisciplinary and social support. (Arq Bras Cardiol. 2017; [online].ahead print, PP.0-0).

Citing Articles

Differences in Health-Related Quality of Life among Patients with Heart Failure.

Ventoulis I, Kamperidis V, Abraham M, Abraham T, Boultadakis A, Tsioukras E Medicina (Kaunas). 2024; 60(1).

PMID: 38256370 PMC: 10818915. DOI: 10.3390/medicina60010109.


Health-related quality of life of people with heart failure in low- and middle-income countries: a systematic review and meta-analysis.

Mulugeta H, Sinclair P, Wilson A Qual Life Res. 2023; 33(5):1175-1189.

PMID: 38070032 DOI: 10.1007/s11136-023-03563-2.


Intermittent Hypoxic Preconditioning Plays a Cardioprotective Role in Doxorubicin-Induced Cardiomyopathy.

Galis P, Bartosova L, Farkasova V, Szobi A, Horvath C, Kovacova D Cardiovasc Toxicol. 2023; 23(5-6):185-197.

PMID: 37119387 DOI: 10.1007/s12012-023-09793-7.


Medication-Attributable Adverse Events in Heart Failure Trials.

Harrington J, Fonarow G, Khan M, Hernandez A, Anker S, Bohm M JACC Heart Fail. 2023; 11(4):425-436.

PMID: 36881395 PMC: 10084875. DOI: 10.1016/j.jchf.2022.11.026.


Physician adherence and patient-reported outcomes in heart failure with reduced ejection fraction in the era of angiotensin receptor-neprilysin inhibitor therapy.

Kim I, Youn J, Jang S, Lee S, Cho H, Choi J Sci Rep. 2022; 12(1):7730.

PMID: 35545653 PMC: 9095619. DOI: 10.1038/s41598-022-11740-5.


References
1.
McDonald K . Current guidelines in the management of chronic heart failure: practical issues in their application to the community population. Eur J Heart Fail. 2005; 7(3):317-21. DOI: 10.1016/j.ejheart.2005.01.013. View

2.
Riegel B, Carlson B, Glaser D, Romero T . Changes over 6-months in health-related quality of life in a matched sample of Hispanics and non-Hispanics with heart failure. Qual Life Res. 2003; 12(6):689-98. DOI: 10.1023/a:1025132623647. View

3.
Lewis E, Lamas G, OMeara E, Granger C, Dunlap M, McKelvie R . Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. Eur J Heart Fail. 2006; 9(1):83-91. DOI: 10.1016/j.ejheart.2006.10.012. View

4.
OMahony M, Sim M, Ho S, Steward J, Buchalter M, Burr M . Diastolic heart failure in older people. Age Ageing. 2003; 32(5):519-24. DOI: 10.1093/ageing/afg090. View

5.
Masoudi F, Rumsfeld J, Havranek E, House J, Peterson E, Krumholz H . Age, functional capacity, and health-related quality of life in patients with heart failure. J Card Fail. 2004; 10(5):368-73. DOI: 10.1016/j.cardfail.2004.01.009. View